$3.15
-0.11[-3.37%]
At close: Apr 22
$3.15
0[0.00%]
PreMarket: 9:27AM EDT
Repare Therapeutics
(NASDAQ:RPTX)Repare Therapeutics Stock (NASDAQ:RPTX), Earnings Estimates, EPS, and Revenue
Repare Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 7
EPS Estimate
$0.020
Quarterly Revenue Estimate
$38.4M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$51.1M
Analyze the earnings history of Repare Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/07/2024 | PM | RPTX | Q1 | -$0.83 | $0.02 | — | — | $5.68M | $38.40M | — | — | Get Alert |
| 02/28/2024 | AM | RPTX | Q4 | -$0.75 | -$0.46 | -$0.67 | -45.65% | $18.20M | $18.93M | $13.05M | -31.08% | Get Alert |
| 11/09/2023 | AM | RPTX | Q3 | $1.71 | -$0.86 | -$0.45 | 47.67% | $112.55M | $6.31M | $2.16M | -65.78% | Get Alert |
| 08/09/2023 | PM | RPTX | Q2 | -$0.91 | -$0.78 | -$0.28 | 64.10% | $679.00K | $7.68M | $30.25M | 293.87% | Get Alert |
| 05/09/2023 | PM | RPTX | Q1 | -$0.83 | -$0.81 | -$0.83 | -2.47% | $408.00K | $6.12M | $5.68M | -7.22% | Get Alert |
| 02/28/2023 | PM | RPTX | Q4 | -$0.70 | -$0.97 | -$0.75 | 22.68% | $6.88M | $10.83M | $18.20M | 68.03% | Get Alert |
| 11/09/2022 | PM | RPTX | Q3 | -$0.83 | -$0.89 | $1.71 | 292.13% | $278.00K | $1.58M | $112.55M | 7023.10% | Get Alert |
| 08/04/2022 | PM | RPTX | Q2 | -$0.71 | -$0.86 | -$0.91 | -5.81% | $279.00K | — | $679.00K | — | Get Alert |
| 05/05/2022 | PM | RPTX | Q1 | -$0.58 | -$0.86 | -$0.83 | 3.49% | $166.00K | $2.35M | $408.00K | -82.64% | Get Alert |
| 03/01/2022 | PM | RPTX | Q4 | -$0.41 | -$0.74 | -$0.70 | 5.41% | $135.00K | $3.28M | $6.88M | 109.66% | Get Alert |
| 11/10/2021 | AM | RPTX | Q3 | -$0.37 | — | -$0.83 | — | $0.00 | — | $278.00K | — | Get Alert |
| 08/12/2021 | PM | RPTX | Q2 | -$2.45 | -$0.60 | -$0.71 | -18.33% | $0.00 | $600.00K | $279.00K | -53.50% | Get Alert |
| 05/13/2021 | PM | RPTX | Q1 | — | -$0.58 | -$0.58 | 0.00% | — | $620.00K | $166.00K | -73.23% | Get Alert |
| 03/04/2021 | PM | RPTX | Q4 | -$5.45 | — | -$0.41 | — | — | — | $135.00K | — | Get Alert |
| 11/11/2020 | AM | RPTX | Q3 | -$5.03 | — | -$0.37 | — | — | — | $0.00 | — | Get Alert |
| 08/13/2020 | PM | RPTX | Q2 | -$4.16 | — | -$2.45 | — | — | — | $0.00 | — | Get Alert |
FAQ
When is Repare Therapeutics (NASDAQ:RPTX) reporting earnings?
Repare Therapeutics (RPTX) is scheduled to report earnings on May 7, 2024. The last reported earnings were for reported on February 28, 2024 for Q4.
What were the latest earnings per share (EPS) for Repare Therapeutics (NASDAQ:RPTX)?
The Actual EPS was $-0.67, which missed the estimate of $-0.46.
What were Repare Therapeutics’s (NASDAQ:RPTX) revenues?
The Actual Revenue was $13M, which missed the estimate of $18.9M.
Browse earnings estimates, EPS, and revenue on all stocks.